Prevention of Antibiotic-Associated Diarrhoea With Prolardii (PAADI)
Double-blind Randomised Placebo-controlled Study of Prolardii Gastro-resistant (GR) Caps in the Prevention and Treatment of Antibiotic-associated Diarrhoea.
Sponsor: ECSOR
A NA clinical study on Antibiotic-associated Diarrhea, this trial is ongoing. The trial is conducted by ECSOR and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
May 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — May 2020 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2017 — May 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ECSOR
- Therabel Pharma SA/NV
For direct contact, visit the study record on ClinicalTrials.gov .